A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail GT

Inclusion Criteria

• •Subject is a male or non-pregnant female age 18 years or older at the time of surgery;
• •Subject is willing and able to give written informed consent and comply with the requirements of this Clinical Investigation Plan;
• •Subject is intended to be treated with the Femoral Nail GT of the T2 Alpha Femur Antegrade GT/PF Nailing System in accordance with the following legally cleared/ approved Indications for Use:
• •Indications for Use approved Outside of Europe include:
• •Fixation of subtrochanteric, intertrochanteric, ipsilateral neck/shaft, comminuted proximal femoral shaft fractures
• •Femoral fixation required as a result of pathological disease
• •Temporary stabilization of fractures of the femoral shaft ranging from the femoral neck to the supracondylar regions of the femur
• •Open and closed femoral fractures
• •Pseudoarthrosis and correction osteotomy
• •Pathologic fractures, impending pathologic fractures and tumor resections
• •Ipsilateral femur fractures
• •Fractures proximal to a total knee arthroplasty
• •Nonunions and malunions
• •Fractures involving osteopenic and osteoporotic bone